Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Puma Biotechnology (NASDAQ: PBYI)

$38.00 USD -$0.35 (-0.91%)
Last Price $38
Net Change $-0.35 (-0.91%)
Bid $36.25
Ask Price $39.8
Open Price $38.45
Previous Close Price $38.35
High Price $38.95
Low Price $37.7
Number of Trades 3,162
Volume 519,900
Fifty Two Week High $73.27 (2016-09-27)
Fifty Two Week Low $19.74 (2016-05-10)
Average Daily Volume 931,442
Share Outstanding 36,950 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $-10.25
Recent Earnings $
Annual EPS $-6.11
Last Quarter EPS $
Market Capitalization $1.40B
Insider Shareholders % 0.227%
Annual Revenue $0B
No. Shares Outstanding 36,950
Inst. Shareholder % 94.54%
Annual Net Income $0B
TTM Net Profit Margin $102.05
1-Year Return 17.72%
3-Year Return -47.15%
5-Year Return 181.48%
5-Year Revenue Growth 0%
5-Year Earnings Growth 528.03%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -10.25%
Dividends per Share $
Stock Split Ratio
Beta 0.39
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the acquisition, in-licensing, development and commercialization of novel therapeutics for the treatment of cancer. Its products under development include PB272 (oral neratinib) for the treatment of patients with human epidermal growth factor receptor type 2 (HER2) positive metastatic breast cancer and gastric cancer and PB272 (neratinib intravenous) for the treatment of patients with advanced cancer. Puma Biotechnology, Inc. is headquartered in Los Angeles, California.